This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing
Tessera Therapeutics is developing a new class of gene editors capable of precisely plugging in long stretches of DNA—something that Crispr can’t do. https://bit.ly/31RPFhg
For the first time, a commercial craft will bring a crew of civilians to the space station. It’s a harbinger of space tourism’s future—and its inequities. https://bit.ly/3jf25HC
Security researchers say the group exploited a zero-day in Apple’s operating system to target European government officials over LinkedIn. https://bit.ly/3kmtpoZ
